Specify a stock or a cryptocurrency in the search bar to get a summary
Apontis Pharma AG
APPHApontis Pharma AG engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany. It offers single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prophylaxis, as well as respiratory diseases and diabetes. The company was founded in 1946 and is based in Monheim am Rhein, Germany. Address: Alfred-Nobel-Str. 10, Monheim am Rhein, Germany, 40789
Analytics
WallStreet Target Price
16.52 EURP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures APPH
Dividend Analytics APPH
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History APPH
Stock Valuation APPH
Financials APPH
Results | 2019 | Dynamics |